Research
Hormonal
GLP-1 agonists resulted in a percentage of change in body weight of -6.2% at six months.
GLP-1 agonists may be an effective option for weight loss in obese IBD patients.
StrongSupportsmedium confidence
The percentage of change in body weight was -6.2 % (-3.4-[-8.5]) at six months.
Why this rating
Based on the retrospective analysis of a specific patient cohort.
Source
Effectiveness and safety of GLP-1 agonist in obese patients with inflammatory bowel disease
Clara Ramos Belinchón et al. · Revista Española de Enfermedades Digestivas · 2024
cohort · n=16Cited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →